Gut microbiota and atherosclerosis: role of B cell for atherosclerosis focusing on the gut-immune-B2 cell axis
Autor: | Kouichi Tamura, Hiroshi Doi, Lin Chen, Tomoaki Ishigami, Kentaro Arakawa |
---|---|
Rok vydání: | 2020 |
Předmět: |
Cell type
Gastrointestinal Diseases Inflammation Review 030204 cardiovascular system & hematology Gut flora Commensal microbiota 03 medical and health sciences 0302 clinical medicine Immune system Antigen Immunity Drug Discovery medicine Animals Humans B2 cells Genetics (clinical) B cell 030304 developmental biology B-Lymphocytes 0303 health sciences biology Atherosclerosis biology.organism_classification Gastrointestinal Microbiome medicine.anatomical_structure Cardiovascular Diseases Immune System Immunology biology.protein Dysbiosis Molecular Medicine Disease Susceptibility medicine.symptom Antibody |
Zdroj: | Journal of Molecular Medicine (Berlin, Germany) |
ISSN: | 1432-1440 0946-2716 |
DOI: | 10.1007/s00109-020-01936-5 |
Popis: | Atherosclerosis is the leading cause of cardiovascular mortality and morbidity worldwide and is described as a complex disease involving several different cell types and their molecular products. Recent studies have revealed that atherosclerosis arises from a systemic inflammatory process, including the accumulation and activities of various immune cells. However, the immune system is a complicated network made up of many cell types, hundreds of bioactive cytokines, and millions of different antigens, making it challenging to readily define the associated mechanism of atherosclerosis. Nevertheless, we previously reported a potential persistent inflammatory process underlying atherosclerosis development, centered on a pathological humoral immune response between commensal microbes and activated subpopulations of substantial B cells in the vicinity of the arterial adventitia. Accumulating evidence has indicated the importance of gut microbiota in atherosclerosis development. Commensal microbiota are considered important regulators of immunity and metabolism and also to be possible antigenic sources for atherosclerosis development. However, the interplay between gut microbiota and metabolism with regard to the modulation of atherosclerosis-associated immune responses remains poorly understood. Here, we review the mechanisms by which the gut microbiota may influence atherogenesis, with particular focus on humoral immunity and B cells, especially the gut-immune-B2 cell axis. Graphical abstract Under high-fat and high-calorie conditions, signals driven by the intestinal microbiota via the TLR signaling pathway cause B2 cells in the spleen to become functionally active and activated B2 cells then modify responses such as antibody production (generation of active antibodies IgG and IgG3), thereby contributing to the development of atherosclerosis. On the other hand, intestinal microbiota also resulted in recruitment and ectopic activation of B2 cells via the TLR signaling pathway in perivascular adipose tissue (PVAT), and, subsequently, an increase in circulating IgG and IgG3 led to the enhanced disease development. This is a potential link between microbiota alterations and B cells in the context of atherosclerosis. |
Databáze: | OpenAIRE |
Externí odkaz: |